Press Releases

2008-12-16
Affibody appoints David Bejker as CEO
The Swedish biotech company Affibody Holding AB (“Affibody”) has appointed David Bejker as CEO.

2008-11-10
Interim Report - January to September 2008
Affibody Holding AB (publ) (“Affibody” or “the Company”), a Swedish biotech company focused on molecular imaging and targeted cancer treatments, today issued its Interim Report covering the nine-month period ended September 30, 2008.

2008-09-05
Interim Report - January to June 2008
Affibody Holding AB (publ) (“Affibody” or “the Company”), a Swedish biotech company focused on molecular imaging and targeted cancer treatments, today issued its Interim Report covering the First Half of 2008.

2008-05-08
Interim Report - January to March 2008
Affibody Holding AB (publ) (“Affibody” or “the Company”), a Swedish biotech company focused on molecular imaging and targeted cancer treatments, today issued its Interim Report covering the First Quarter 2008.

2008-03-27
Unexpected Discovery Made by Swedish Researchers within the Field of Alzheimer: Newly Discovered Protein Inhibits the Formation of the Precursor to Alzheimer’s Plaques.
STOCKHOLM, Sweden, March 27, 2008. As of today, there is no cure or effective treatment of Alzheimer’s disease. Swedish researchers have now through their discoveries opened up new possible strategies for potential treatment of the actual cause of the disease. These results have been obtained through a fruitful collaboration between researchers from Sahlgrenska Academy at University of Gothenburg, Royal Institute of Technology (Kungliga Tekniska Högskolan, KTH) and the company Affibody AB.

2008-02-07
Year-End Report 2007 in summary
Affibody Holding AB (publ) (“Affibody” or “the Company”), a Swedish biotech company focused on molecular imaging and targeted cancer treatments, today issued its report for the full year 2007 in summary